1. Home
  2. NRXP
  3. NRXP News

Latest NRX Pharmaceuticals Inc. (NRXP) News on October 6, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic
NRXP

PR Newswire

3 days ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)
NRXP

PR Newswire

6 days ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
NRXP

PR Newswire

25 days ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
NRXP

PR Newswire

a month ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
NRXP

PR Newswire

a month ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
NRXP

PR Newswire

2 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024
NRXP

PR Newswire

2 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds
NRXP

PR Newswire

2 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)
NRXP

PR Newswire

2 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
NRXP

PR Newswire

3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
NRXP

PR Newswire

3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRXP

PR Newswire

4 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
NRXP

PR Newswire

4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
NRXP

PR Newswire

4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipolar Depression
NRXP

PR Newswire

4 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
NRXP

PR Newswire

5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
NRXP

ACCESSWIRE

5 months ago

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
NRXP

PR Newswire

5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
NRXP

PR Newswire

5 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
NRXP

PR Newswire

5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression
NRXP

PR Newswire

5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
NRXP

PR Newswire

6 months ago

UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK
NRXP

PR Newswire

6 months ago

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024

NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders
NRXP

PR Newswire

6 months ago

NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales

NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock
NRXP

Simply Wall St.

7 months ago

Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
NRXP

PR Newswire

7 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
NRXP

PR Newswire

8 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
NRXP

PR Newswire

8 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
NRXP

PR Newswire

8 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon
NRXP

PR Newswire

8 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation
NRXP

Simply Wall St.

8 months ago

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
NRXP

GlobeNewswire

8 months ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Mid Penn Bancorp Full Year 2023 Earnings: EPS Misses Expectations
NRXP

Simply Wall St.

8 months ago

Mid Penn Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NRXP

GlobeNewswire

8 months ago

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal
NRXP

Zacks

8 months ago

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
NRXP

GlobeNewswire

8 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
NRXP

PR Newswire

8 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRXP

GlobeNewswire

9 months ago

New Era Helium Corp. and Roth CH Acquisition V Co. announce the Filing of an Investor Presentation for the Proposed Business Combination

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination
NRXP

PR Newswire

9 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis
NRXP

PR Newswire

9 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis

MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross
NRXP

Zacks

9 months ago

MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross

Alico, Inc. to Present at Sidoti Virtual Investor Conference
NRXP

GlobeNewswire

9 months ago

Alico, Inc. to Present at Sidoti Virtual Investor Conference

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
NRXP

GlobeNewswire

9 months ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

NRXP

Zacks

9 months ago

Top Stock Picks for Week of January 8, 2024

The Container Store lowers Q3 sales guidance
NRXP

Retail Dive

9 months ago

The Container Store lowers Q3 sales guidance

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation
NRXP

Business Wire

9 months ago

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation

Stronghold Digital Mining and Elbit Systems have been highlighted as Zacks Bull and Bear of the Day
NRXP

Zacks

9 months ago

Stronghold Digital Mining and Elbit Systems have been highlighted as Zacks Bull and Bear of the Day

NRXP

GlobeNewswire

9 months ago

New Era Helium Corp. to List on NASDAQ Through Merger with Roth CH Acquisition V Co.

Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
NRXP

Zacks

9 months ago

Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva

NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco
NRXP

PR Newswire

9 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco

NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard
NRXP

PR Newswire

9 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard

NRx Pharmaceuticals Announces the Election of Janet Rehnquist to its Board of Directors
NRXP

PR Newswire

9 months ago

NRx Pharmaceuticals Announces the Election of Janet Rehnquist to its Board of Directors

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership
NRXP

Simply Wall St.

9 months ago

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership

One CytoMed Therapeutics Insider Raised Stake By 46% In Previous Year
NRXP

Simply Wall St.

10 months ago

One CytoMed Therapeutics Insider Raised Stake By 46% In Previous Year

First United Corporation's (NASDAQ:FUNC) top owners are individual investors with 59% stake, while 32% is held by institutions
NRXP

Simply Wall St.

10 months ago

First United Corporation's (NASDAQ:FUNC) top owners are individual investors with 59% stake, while 32% is held by institutions

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension
NRXP

GlobeNewswire

10 months ago

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension

NRXP

Thomson Reuters StreetEvents

10 months ago

Q3 2024 Conn's Inc Earnings Call

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
NRXP

PR Newswire

10 months ago

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression

Conn's (CONN) Reports Q3 Loss, Misses Revenue Estimates
NRXP

Zacks

10 months ago

Conn's (CONN) Reports Q3 Loss, Misses Revenue Estimates

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
NRXP

GlobeNewswire

10 months ago

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections
NRXP

PR Newswire

10 months ago

NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections

Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
NRXP

Zacks

10 months ago

Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up

Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
NRXP

GlobeNewswire

10 months ago

Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic

Allbirds begins selling on Amazon
NRXP

Retail Dive

10 months ago

Allbirds begins selling on Amazon

Farmer Bros Interim Independent Chairman of the Board Acquires 94% More Stock
NRXP

Simply Wall St.

a year ago

Farmer Bros Interim Independent Chairman of the Board Acquires 94% More Stock

NRXP

Thomson Reuters StreetEvents

a year ago

Q3 2023 BioXcel Therapeutics Inc Earnings Call

Fossil Group, Inc. (NASDAQ:FOSL) Q3 2023 Earnings Call Transcript
NRXP

Insider Monkey

a year ago

Fossil Group, Inc. (NASDAQ:FOSL) Q3 2023 Earnings Call Transcript

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript
NRXP

Insider Monkey

a year ago

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

NRXP

Associated Press Finance

a year ago

Xoma: Q3 Earnings Snapshot

NRXP

Thomson Reuters StreetEvents

a year ago

Q3 2023 Great Ajax Corp Earnings Call

NRXP

GuruFocus.com

a year ago

Great Ajax Corp (AJX) Reports Q3 2023 Earnings, Net Loss of $6.1 Million

NRXP

Associated Press Finance

a year ago

Great Ajax: Q3 Earnings Snapshot

Great Ajax Corp. Announces Results for the Quarter Ended September 30, 2023; Provides Strategic Update
NRXP

Business Wire

a year ago

Great Ajax Corp. Announces Results for the Quarter Ended September 30, 2023; Provides Strategic Update

Share on Social Networks: